YS Biopharma Co, Price on December 31, 2023

YS Biopharma Valuation on December 31, 2023

YS Biopharma Trading Date Momentum on December 31, 2023

On January 02 2024 YS Biopharma Co, was traded for  0.51  at the closing time. The highest price during the trading period was 0.54  and the lowest recorded bid was listed for  0.51 . The volume for the day was 47.9 K. This history from January 2, 2024 had no short-term effect on price fluctuation. The trading price change to the current price is 7.84% .

YS Biopharma Co, Fundamentals Correlations and Trends

By evaluating YS Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among YS Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. YS Biopharma financial account trend analysis is a perfect complement when working with valuation or volatility modules.

YS Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for YS Biopharma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in YS Biopharma Co, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing YS Biopharma stock prices may prove useful in developing a viable investing in YS Biopharma

YS Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.

Market strength indicators help investors to evaluate how YS Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading YS Biopharma shares will generate the highest return on investment. By undertsting and applying YS Biopharma stock market strength indicators, traders can identify YS Biopharma Co, entry and exit signals to maximize returns

Predictive indicators are helping investors to find signals for YS Biopharma's price direction in advance. Along with the technical and fundamental analysis of YS Biopharma Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of YS Biopharma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

If you are still planning to invest in YS Biopharma Co, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the YS Biopharma's history and understand the potential risks before investing.